Illumina Posts 31 Percent Q2 Revenue Growth; Acquires PCR Instruments Firm

Illumina's revenues rose sharply on rapid uptake of its HiSeq system. The firm also acquired Helixis for up to $105 million, providing it with a new, low-cost, real-time PCR system for genetic analysis.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.